Reasons for ineligibility for clinical trials of patients with medication-resistant epilepsy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Wesley T,Kerr

第一单位： Department of Neurology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

作者： Wesley T,Kerr ^[1] ; Hai,Chen ^[2] ; Mariana,Figuera Losada ^[3] ; Christopher,Cheng ^[4] ; Tiffany,Liu ^[5] ; Jaqueline,French ^[3]

作者单位： Department of Neurology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA. ^[1] Comprehensive Epilepsy Center, New York University Langone Medical Center, New York, New York, USA.;Department of Neurology, George Washington University, Washington, District of Columbia, USA.;Department of Neurology, Weill Cornell Medicine, New York, New York, USA. ^[2] Comprehensive Epilepsy Center, New York University Langone Medical Center, New York, New York, USA. ^[3] Comprehensive Epilepsy Center, New York University Langone Medical Center, New York, New York, USA.;West Coast Neurology, Pasadena, California, USA. ^[4] Comprehensive Epilepsy Center, New York University Langone Medical Center, New York, New York, USA.;Department of Neurology, Oschner Health, New Orleans, Louisiana, USA.;Louisiana State University Health Science, Lafayette Campus, New Orleans, Louisiana, USA. ^[5]

关键词 antiepileptic drug antiseizure medication clinical trial design drug-resistant epilepsy

主题词人类(Humans);抗惊厥药(Anticonvulsants);回顾性研究(Retrospective Studies);发作(Seizures);癫痫(Epilepsy);癫痫, 全身性(Epilepsy, Generalized)

DOI 10.1111/epi.17568

PMID 36869635

发布时间 2023-05-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交